Rekombinanter APOA2 Antikörper
-
- Target Alle APOA2 Antikörper anzeigen
- APOA2 (Apolipoprotein A-II (APOA2))
- Antikörpertyp
- Recombinant Antibody
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser APOA2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Flow Cytometry (FACS)
- Kreuzreaktivität
- Human
- Aufreinigung
- Affinity-chromatography
- Immunogen
- A synthesized peptide derived from human APOA2
- Klon
- 6H2
- Isotyp
- IgG
- Top Product
- Discover our top product APOA2 Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: WB:1:500-1:5000, IHC:1:50-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- APOA2 (Apolipoprotein A-II (APOA2))
- Andere Bezeichnung
- APOA2 (APOA2 Produkte)
- Synonyme
- Apo-AII antikoerper, ApoA-II antikoerper, apoAII antikoerper, Alp-2 antikoerper, ApoAII antikoerper, Apoa-2 antikoerper, Hdl-1 antikoerper, APOAII antikoerper, apoa2 antikoerper, apoA-II antikoerper, cb1032 antikoerper, wu:fb57h11 antikoerper, zgc:193613 antikoerper, apolipoprotein A2 antikoerper, apolipoprotein A-II antikoerper, APOA2 antikoerper, Apoa2 antikoerper, apoa2 antikoerper
- Hintergrund
-
Background: May stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism.
Aliases: Apolipoprotein A-II, Apo-AII, ApoA-II, Apolipoprotein A2, Proapolipoprotein A-II, ProapoA-II, Truncated apolipoprotein A-II, Apolipoprotein A-II(1-76), APOA2
- UniProt
- P02652
- Pathways
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
-